CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
NCT Number: NCT03101410
This clinical project aims to study the relationship between gluten consumption and its impact on digestive comfort, quality of life and performance of non-celiac athletes practicing an intensive physical activity..
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Clermont-Ferrand, 63003, France
Gluten is a protein network that results from both, the hydration and the kneading of storage proteins contained in the endosperm of certain cereals. Gluten is particularly found in bread products but it is also found in many processed products because of its physicochemical properties (binding, swelling properties ...). This omnipresence is now blamed, and a growing percentage of the population reports "intolerance" to gluten. This gluten sensitivity hypothesis is frequently associated with intestinal disorders (irritable bowel syndrome, bloating, abdominal pain, chronic diarrhea, constipation) but also with headache, fatigue, muscle and joint aches, bone fragility, migraine, eczema, depression, anxiety .... This assumption has led to the adoption of increasingly frequent gluten-free diets among the general population, without medical justification.
Among the population, athletes are particularly concerned due to a higher prevalence of anaphylaxis dependent on the combination of physical exercise and food intake (Maulitz and Kidd syndrome). This syndrome is notably reported with consumption of cereals in particular wheat (bread, pasta). However, these conditions are poorly described with regards to gluten and scientific investigations are required to rationally characterize the benefits of gluten-free diets for elite athletes.
Therefore, this clinical project aims to study the relationship between gluten consumption and its impact on digestive comfort, quality of life and performance of non-celiac athletes practicing an intensive physical activity.
All the participants will give freely their written informed consent before their selection in the study.
Information on physical activities, demographics, anthropometrics, vital signs, relevant medical history and concomitant medication, dietary habits, usual dietary intake and nutritional supplements will be collected. All inclusion and exclusion criteria will be checked by the investigator or co-investigator.
Selected participants will be randomly allocated to treatment group (gluten or gluten free). Couple from the same family will be randomised in the same group.
After 2 months, all subjects will have the diet without gluten.
All recruited volunteers will be asked to replace their bread and pasta intake by study products (pasta and white bread with or without gluten), maintain their usual dietary habits and continue their normal physical habits.
Each 2 months, volunteers will have a physical performance assessment and will provide a blood and faeces samples. All volunteers will complete a follow-up questionnaire to obtain information about any changes in medication use, disease etc. Each week, all subjects will complete a questionnaire related to digestive function :Food Benefits Assessment (FBA)).
At the beginning and 2 months, usual dietary intakes will be estimated by means of a 3- days food records.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Selected participants will be randomly allocated to treatment group (gluten or gluten free).
Selected participants will be randomly allocated to treatment group (gluten or gluten free).
Time frame: at the beginning of the study, at 2 month and 4 month
Time frame: at the beginning of the study, at 2 month and 4 month
Time frame: at the beginning of the study, at 2 month and 4 month
Microbiote composition will be measured by qPCR, targeting 16S gene
Time frame: at the beginning of the study, at 2 month and 4 month
Time frame: at the beginning of the study, at 2 month and 4 month
Time frame: at the beginning of the study, at 2 month and 4 month
Time frame: at the beginning of the study, at 2 month and 4 month
Time frame: at the beginning of the study, at 2 month and 4 month
Their reactivity will be studied in the presence of three different forms of gliadins: native, deaminated and hydrolysed
University Hospital, Clermont-Ferrand
Other
Acronym: GLUTHEALTH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06872151
Anus Diseases, Cardiovascular Diseases
Monserrato, Cagliari, Italy
View Trial DetailsNCT06201559
Digestive System Diseases, Gastrointestinal Diseases
Ahmedabad, India
View Trial DetailsNCT02831556
Abdominal Injuries, Adnexal Diseases
Durham, North Carolina, United States
View Trial DetailsNCT02647866
Abdominal Pain, Autoimmune Disease
Greenville, South Carolina, United States
View Trial Details